Diabetic Macular Edema

>

The HCPLive diabetic macular edema page is a comprehensive resource for clinical news and insights on DME. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for the leading cause of blindness, and more.

Latest News

| Image Credit: NCI/Unsplash
52-Week Data Support MYL-1701P as Aflibercept Biosimilar for DME

September 12th 2024

MYL-1701P showed equivalent efficacy, with comparable safety and immunogenicity, to reference aflibercept in the Phase 3 INSIGHT trial.

Ophthalmology Month in Review: August 2024 | Image Credit: HCPLive
Ophthalmology Month in Review: August 2024

September 3rd 2024

Treatment Order with Panretinal Photocoagulation Influences PDR Outcomes | Image Credit: Stanford University
Treatment Order with Panretinal Photocoagulation Influences PDR Outcomes

August 29th 2024

Switch to Faricimab Improves Short-Term Anatomical Outcomes in DME | Image Credit: LinkedIn
Switch to Faricimab Improves Short-Term Anatomical Outcomes in DME

August 28th 2024

Metabolic Risk Factors Contribute to Diabetic Macular Edema Development | Image Credit: Victor Freitas/Unsplash
Metabolic Risk Factors Contribute to Diabetic Macular Edema Development

August 23rd 2024

<1
...
212223242526>
© 2024 MJH Life Sciences

All rights reserved.